✦ LIBER ✦

Dose Intensity : The Neglected Variable in Clinical Trials

✍ Scribed by ANTONELLA SURBONE; VINCENT T. DeVITA Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neglect of aged in clinical trials

✍ J.L. Kannry; T.C. Chalmers; T.C. Orza; M. Reitman; D. Brown 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Dose Titration in Clinical Trials

✍ J. A. MASSEY; P. ABRAMS 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

Clinical trial variability: Quality cont

✍ Marion McGregor; Jerrilyn A. Cambron; James Jedlicka; M. Ram Gudavalli 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

ICRU reference dose in an era of intensi

✍ Ravindra Yaparpalvi; Linda Hong; Dennis Mah; Jin Shen; Subhakar Mutyala; Marnee 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB

The final dose of clinical trial designs

✍ Michael G. Wyllie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

SURGEON-RELATED VARIABLES AND THE CLINIC

✍ Fielding, L.P.; Stewart-Brown, Sarah; Dudley, H.A.F. 📂 Article 📅 1978 🏛 The Lancet 🌐 English ⚖ 301 KB